Safety Information
| Description | Publish Date | LINKS |
|---|---|---|
| Salbutamol pMDI, Advisory Letter | 12/08/2025 |  |
| Important safety information on Dolutegravir in Azerbaijan |
10/10/2018 |
|
| Important safety information on Belimumab in Azerbaijan |
22/02/2019 | |
| Important safety information on Cephalosporins in Azerbaijan (Safety Notification_Cephalosporins and risk of seizure) | 01/03/2023 | |
Important safety information on Cephalosporins in Azerbaijan (Safety Notification_Cephalosporins and risk of neurotoxicity) |
07/03/2023 |
|
| Important safety information on Amoxicillin / Amoxicillin and clavulanic acid containing products in Azerbaijan | 09/09/2023 | |
| Important safety information on Dolutegravir in Azerbaijan (Safety Notification_Korean label update for Dolutegravir containing products) | 01/11/2023 | |
| Important safety information on Topical Corticosteroids containing products in Azerbaijan | 15-11-2023 | |
| Important safety information on Hepatitis B surface antigen recombinant vaccine in Azerbaijan (Initial Safety Notification Engerix-B and Myelitis_November 2023) | 17-11-2023 | |
| Important safety information on Hepatitis B surface antigen recombinant vaccine in Azerbaijan (Updated Safety Notification Engerix-B and Myelitis_December 2023) | 02-01-2024 | |
